N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-N'-propan-2-ylsulfonylpentanediamide;1-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-3-[2-methyl-3-(propan-2-ylsulfonylamino)propyl]urea;N-(1,3-dioxo-2-phenylisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-ethyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;4-methyl-N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide

C166H234ClN21O37S8 — CID 161290109

IUPACN-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-N'-propan-2-ylsulfonylpentanediamide;1-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-3-[2-methyl-3-(propan-2-ylsulfonylamino)propyl]urea;N-(1,3-dioxo-2-phenylisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-ethyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;4-methyl-N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide
SMILESCC(C)CC(NC(=O)CCCCNS(=O)(=O)C(C)C)C1(c2ccc(Cl)cc2)CCC1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc2c(c1)C(=O)N(c1ccccc1)C2=O.CC(C)c1cc(NC(=O)CCCCNS(=O)(=O)C(C)C)cc2ccc(=O)oc12.CC(CCC(=O)Nc1ccc2oc(=O)ccc2c1)CNS(=O)(=O)C(C)C.CC(CNC(=O)Nc1ccc(N2C[C@@H](C)O[C@@H](C)C2)cc1)CNS(=O)(=O)C(C)C.CCc1cc(NC(=O)CCCCNS(=O)(=O)C(C)C)cc2ccc(=O)oc12.Cc1cc(N2C[C@@H](C)O[C@@H](C)C2)ccc1NC(=O)CCCC(=O)NS(=O)(=O)C(C)C.Cc1ccc(N2C(=O)c3ccc(NC(=O)CCCCNS(=O)(=O)C(C)C)cc3C2=O)cc1
InChIInChI=1S/C23H37ClN2O3S.C23H27N3O5S.C22H25N3O5S.C21H33N3O5S.C20H34N4O4S.C20H28N2O5S.C19H26N2O5S.C18H24N2O5S/c1-17(2)16-21(23(13-7-14-23)19-9-11-20(24)12-10-19)26-22(27)8-5-6-15-25-30(28,29)18(3)4;1-15(2)32(30,31)24-13-5-4-6-21(27)25-17-9-12-19-20(14-17)23(29)26(22(19)28)18-10-7-16(3)8-11-18;1-15(2)31(29,30)23-13-7-6-10-20(26)24-16-11-12-18-19(14-16)22(28)25(21(18)27)17-8-4-3-5-9-17;1-14(2)30(27,28)23-21(26)8-6-7-20(25)22-19-10-9-18(11-15(19)3)24-12-16(4)29-17(5)13-24;1-14(2)29(26,27)22-11-15(3)10-21-20(25)23-18-6-8-19(9-7-18)24-12-16(4)28-17(5)13-24;1-13(2)17-12-16(11-15-8-9-19(24)27-20(15)17)22-18(23)7-5-6-10-21-28(25,26)14(3)4;1-4-14-11-16(12-15-8-9-18(23)26-19(14)15)21-17(22)7-5-6-10-20-27(24,25)13(2)3;1-12(2)26(23,24)19-11-13(3)4-8-17(21)20-15-6-7-16-14(10-15)5-9-18(22)25-16/h9-12,17-18,21,25H,5-8,13-16H2,1-4H3,(H,26,27);7-12,14-15,24H,4-6,13H2,1-3H3,(H,25,27);3-5,8-9,11-12,14-15,23H,6-7,10,13H2,1-2H3,(H,24,26);9-11,14,16-17H,6-8,12-13H2,1-5H3,(H,22,25)(H,23,26);6-9,14-17,22H,10-13H2,1-5H3,(H2,21,23,25);8-9,11-14,21H,5-7,10H2,1-4H3,(H,22,23);8-9,11-13,20H,4-7,10H2,1-3H3,(H,21,22);5-7,9-10,12-13,19H,4,8,11H2,1-3H3,(H,20,21)/t;;;16-,17+;15?,16-,17+;;;
InChIKeyVGFSYWFTZDVLST-XBKOSUPISA-N
MW3407.80 g/mol
LogP24.52
Rot. Bonds72

About N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-N'-propan-2-ylsulfonylpentanediamide;1-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-3-[2-methyl-3-(propan-2-ylsulfonylamino)propyl]urea;N-(1,3-dioxo-2-phenylisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-ethyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;4-methyl-N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide

N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-N'-propan-2-ylsulfonylpentanediamide;1-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-3-[2-methyl-3-(propan-2-ylsulfonylamino)propyl]urea;N-(1,3-dioxo-2-phenylisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-ethyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;4-methyl-N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide (PubChem CID 161290109) has the molecular formula C166H234ClN21O37S8 and a molecular weight of 3407.80 g/mol. Its IUPAC name is N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-N'-propan-2-ylsulfonylpentanediamide;1-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-3-[2-methyl-3-(propan-2-ylsulfonylamino)propyl]urea;N-(1,3-dioxo-2-phenylisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-ethyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;4-methyl-N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide.

Molecular Properties

Compound NameN-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-N'-propan-2-ylsulfonylpentanediamide;1-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-3-[2-methyl-3-(propan-2-ylsulfonylamino)propyl]urea;N-(1,3-dioxo-2-phenylisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-ethyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;4-methyl-N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide
PubChem CID161290109
Molecular FormulaC166H234ClN21O37S8
Molecular Weight3407.80 g/mol
Exact Mass3404.45
IUPAC NameN-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-N'-propan-2-ylsulfonylpentanediamide;1-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-3-[2-methyl-3-(propan-2-ylsulfonylamino)propyl]urea;N-(1,3-dioxo-2-phenylisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-ethyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;4-methyl-N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide
SMILESCC(C)CC(NC(=O)CCCCNS(=O)(=O)C(C)C)C1(c2ccc(Cl)cc2)CCC1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc2c(c1)C(=O)N(c1ccccc1)C2=O.CC(C)c1cc(NC(=O)CCCCNS(=O)(=O)C(C)C)cc2ccc(=O)oc12.CC(CCC(=O)Nc1ccc2oc(=O)ccc2c1)CNS(=O)(=O)C(C)C.CC(CNC(=O)Nc1ccc(N2C[C@@H](C)O[C@@H](C)C2)cc1)CNS(=O)(=O)C(C)C.CCc1cc(NC(=O)CCCCNS(=O)(=O)C(C)C)cc2ccc(=O)oc12.Cc1cc(N2C[C@@H](C)O[C@@H](C)C2)ccc1NC(=O)CCCC(=O)NS(=O)(=O)C(C)C.Cc1ccc(N2C(=O)c3ccc(NC(=O)CCCCNS(=O)(=O)C(C)C)cc3C2=O)cc1
InChIInChI=1S/C23H37ClN2O3S.C23H27N3O5S.C22H25N3O5S.C21H33N3O5S.C20H34N4O4S.C20H28N2O5S.C19H26N2O5S.C18H24N2O5S/c1-17(2)16-21(23(13-7-14-23)19-9-11-20(24)12-10-19)26-22(27)8-5-6-15-25-30(28,29)18(3)4;1-15(2)32(30,31)24-13-5-4-6-21(27)25-17-9-12-19-20(14-17)23(29)26(22(19)28)18-10-7-16(3)8-11-18;1-15(2)31(29,30)23-13-7-6-10-20(26)24-16-11-12-18-19(14-16)22(28)25(21(18)27)17-8-4-3-5-9-17;1-14(2)30(27,28)23-21(26)8-6-7-20(25)22-19-10-9-18(11-15(19)3)24-12-16(4)29-17(5)13-24;1-14(2)29(26,27)22-11-15(3)10-21-20(25)23-18-6-8-19(9-7-18)24-12-16(4)28-17(5)13-24;1-13(2)17-12-16(11-15-8-9-19(24)27-20(15)17)22-18(23)7-5-6-10-21-28(25,26)14(3)4;1-4-14-11-16(12-15-8-9-18(23)26-19(14)15)21-17(22)7-5-6-10-20-27(24,25)13(2)3;1-12(2)26(23,24)19-11-13(3)4-8-17(21)20-15-6-7-16-14(10-15)5-9-18(22)25-16/h9-12,17-18,21,25H,5-8,13-16H2,1-4H3,(H,26,27);7-12,14-15,24H,4-6,13H2,1-3H3,(H,25,27);3-5,8-9,11-12,14-15,23H,6-7,10,13H2,1-2H3,(H,24,26);9-11,14,16-17H,6-8,12-13H2,1-5H3,(H,22,25)(H,23,26);6-9,14-17,22H,10-13H2,1-5H3,(H2,21,23,25);8-9,11-14,21H,5-7,10H2,1-4H3,(H,22,23);8-9,11-13,20H,4-7,10H2,1-3H3,(H,21,22);5-7,9-10,12-13,19H,4,8,11H2,1-3H3,(H,20,21)/t;;;16-,17+;15?,16-,17+;;;
InChIKeyVGFSYWFTZDVLST-XBKOSUPISA-N
XLogP24.52
TPSA821.59 Ų
H-Bond Donors17
H-Bond Acceptors39
Rotatable Bonds72
Heavy Atoms233
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003407.80
LogP ≤ 524.52
H-Bond Donors ≤ 517
H-Bond Acceptors ≤ 1039

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'cumarine', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-N'-propan-2-ylsulfonylpentanediamide;1-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-3-[2-methyl-3-(propan-2-ylsulfonylamino)propyl]urea;N-(1,3-dioxo-2-phenylisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-ethyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;4-methyl-N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[2-(4-butan-2-ylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-3-ethyl-2-fluorophenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-fluoro-3-methylphenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-N'-propan-2-ylsulfonylpentanediamide;1-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-3-[2-methyl-3-(propan-2-ylsulfonylamino)propyl]urea;N-(1,3-dioxo-2-phenylisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-ethyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;4-methyl-N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-(1-phenyltetrazol-5-yl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide
CID 160646702
4-(tert-butylsulfonylamino)-N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]cyclohexane-1-carboxamide;4-(tert-butylsulfonylamino)-N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]cyclohexane-1-carboxamide;4-(tert-butylsulfonylamino)-N-(1,3-dioxo-2-phenylisoindol-5-yl)cyclohexane-1-carboxamide;4-(tert-butylsulfonylamino)-N-[4-(1-methyltetrazol-5-yl)phenyl]cyclohexane-1-carboxamide;4-(tert-butylsulfonylamino)-N-(2-oxochromen-6-yl)cyclohexane-1-carboxamide;5-(tert-butylsulfonylamino)-N-(2-oxochromen-6-yl)pentanamide;4-(tert-butylsulfonylamino)-N-(5-phenylpyrazin-2-yl)cyclohexane-1-carboxamide;4-(tert-butylsulfonylamino)-N-[4-(1-phenyltetrazol-5-yl)phenyl]cyclohexane-1-carboxamide;4-(tert-butylsulfonylamino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)cyclohexane-1-carboxamide;1-[3-(tert-butylsulfonylamino)propyl]-3-[4-[(2R,6S)-2,6-dimethylmorpholin-4-yl]phenyl]urea;N'-tert-butylsulfonyl-N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]pentanediamide;2-(1-tert-butylsulfonylpiperidin-4-yl)-N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]acetamide;N-(2-oxochromen-6-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide
CID 159544105
N-(3-acetyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-(benzenesulfonamido)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylphenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-(methanesulfonamido)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-methyl-1,3-dioxoisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-methyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(5-phenylpyrazin-2-yl)-5-(propan-2-ylsulfonylamino)pentanamide
CID 157245386
N-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-3-methylphenyl]-4-(propan-2-ylsulfonylamino)piperidine-1-carboxamide;N-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]phenyl]-2-methyl-4-(propan-2-ylsulfonylamino)piperidine-1-carboxamide;N-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]phenyl]-3-methyl-4-(propan-2-ylsulfonylamino)piperidine-1-carboxamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-3-ethyl-2-fluorophenyl]-4-(propan-2-ylsulfonylamino)piperidine-1-carboxamide;N-[4-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-2-fluoro-3-methylphenyl]-4-(propan-2-ylsulfonylamino)piperidine-1-carboxamide;N-(1,3-dioxo-2-phenylisoindol-5-yl)-4-(propan-2-ylsulfonylamino)piperidine-1-carboxamide;N-(1,3-dioxo-2-propan-2-ylisoindol-5-yl)-4-(propan-2-ylsulfonylamino)piperidine-1-carboxamide;N-[1,3-dioxo-2-(4-propan-2-ylphenyl)isoindol-5-yl]-4-(propan-2-ylsulfonylamino)piperidine-1-carboxamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-4-(propan-2-ylsulfonylamino)piperidine-1-carboxamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-4-(propan-2-ylsulfonylamino)piperidine-1-carboxamide
CID 159132602
N-[2-(4-butan-2-ylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide
CID 20629318
N-[4-(2,6-dimethylmorpholin-4-yl)-3-methylphenyl]-5-(propan-2-ylsulfonylamino)pentanamide
CID 20630093
5-(tert-butylsulfonylamino)-N-(4-cyanophenyl)pentanamide;5-(tert-butylsulfonylamino)-N-[3-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]pentanamide;5-(tert-butylsulfonylamino)-N-(4-ethylphenyl)pentanamide;5-(tert-butylsulfonylamino)-N-(4-methylphenyl)pentanamide;5-(tert-butylsulfonylamino)-N-(3-morpholin-4-ylphenyl)pentanamide;5-(tert-butylsulfonylamino)-N-phenylpentanamide;5-(tert-butylsulfonylamino)-N-(4-propylphenyl)pentanamide;N-[1,3-dioxo-2-[4-(trifluoromethyl)phenyl]isoindol-5-yl]-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide
CID 160925101
N-(5-chloro-2-methoxyphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(2,4-dichlorophenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(3,4-dichlorophenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(3,4-dimethoxyphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-2,3-difluorophenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2,3,5,6-tetrafluorophenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(3R,5R)-3,5-dimethylpiperidin-1-yl]phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(3-fluoro-4-methoxyphenyl)-5-(propan-2-ylsulfonylamino)pentanamide
CID 162177584
N-(2-methyl-1,3-dioxoisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide
CID 20629138
N-[2-methyl-5-[(2-oxochromen-6-yl)amino]pentyl]propane-2-sulfonamide
CID 89118476
N-[5-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylanilino]pentyl]propane-2-sulfonamide
CID 70939255
2-(4-chlorophenyl)-N-(1,3-dioxo-2-phenylisoindol-5-yl)acetamide
CID 1300069

Frequently Asked Questions

What is the IUPAC name of N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-N'-propan-2-ylsulfonylpentanediamide;1-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-3-[2-methyl-3-(propan-2-ylsulfonylamino)propyl]urea;N-(1,3-dioxo-2-phenylisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-ethyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;4-methyl-N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide?
The IUPAC name of N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-N'-propan-2-ylsulfonylpentanediamide;1-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-3-[2-methyl-3-(propan-2-ylsulfonylamino)propyl]urea;N-(1,3-dioxo-2-phenylisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-ethyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;4-methyl-N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide (CID 161290109) is N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-N'-propan-2-ylsulfonylpentanediamide;1-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-3-[2-methyl-3-(propan-2-ylsulfonylamino)propyl]urea;N-(1,3-dioxo-2-phenylisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-ethyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;4-methyl-N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide.
What is the SMILES notation for N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-N'-propan-2-ylsulfonylpentanediamide;1-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-3-[2-methyl-3-(propan-2-ylsulfonylamino)propyl]urea;N-(1,3-dioxo-2-phenylisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-ethyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;4-methyl-N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide?
The canonical SMILES for N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-N'-propan-2-ylsulfonylpentanediamide;1-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-3-[2-methyl-3-(propan-2-ylsulfonylamino)propyl]urea;N-(1,3-dioxo-2-phenylisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-ethyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;4-methyl-N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide is CC(C)CC(NC(=O)CCCCNS(=O)(=O)C(C)C)C1(c2ccc(Cl)cc2)CCC1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc2c(c1)C(=O)N(c1ccccc1)C2=O.CC(C)c1cc(NC(=O)CCCCNS(=O)(=O)C(C)C)cc2ccc(=O)oc12.CC(CCC(=O)Nc1ccc2oc(=O)ccc2c1)CNS(=O)(=O)C(C)C.CC(CNC(=O)Nc1ccc(N2C[C@@H](C)O[C@@H](C)C2)cc1)CNS(=O)(=O)C(C)C.CCc1cc(NC(=O)CCCCNS(=O)(=O)C(C)C)cc2ccc(=O)oc12.Cc1cc(N2C[C@@H](C)O[C@@H](C)C2)ccc1NC(=O)CCCC(=O)NS(=O)(=O)C(C)C.Cc1ccc(N2C(=O)c3ccc(NC(=O)CCCCNS(=O)(=O)C(C)C)cc3C2=O)cc1.
What is the InChIKey of N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-N'-propan-2-ylsulfonylpentanediamide;1-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-3-[2-methyl-3-(propan-2-ylsulfonylamino)propyl]urea;N-(1,3-dioxo-2-phenylisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-ethyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;4-methyl-N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide?
The InChIKey is VGFSYWFTZDVLST-XBKOSUPISA-N. The full InChI is InChI=1S/C23H37ClN2O3S.C23H27N3O5S.C22H25N3O5S.C21H33N3O5S.C20H34N4O4S.C20H28N2O5S.C19H26N2O5S.C18H24N2O5S/c1-17(2)16-21(23(13-7-14-23)19-9-11-20(24)12-10-19)26-22(27)8-5-6-15-25-30(28,29)18(3)4;1-15(2)32(30,31)24-13-5-4-6-21(27)25-17-9-12-19-20(14-17)23(29)26(22(19)28)18-10-7-16(3)8-11-18;1-15(2)31(29,30)23-13-7-6-10-20(26)24-16-11-12-18-19(14-16)22(28)25(21(18)27)17-8-4-3-5-9-17;1-14(2)30(27,28)23-21(26)8-6-7-20(25)22-19-10-9-18(11-15(19)3)24-12-16(4)29-17(5)13-24;1-14(2)29(26,27)22-11-15(3)10-21-20(25)23-18-6-8-19(9-7-18)24-12-16(4)28-17(5)13-24;1-13(2)17-12-16(11-15-8-9-19(24)27-20(15)17)22-18(23)7-5-6-10-21-28(25,26)14(3)4;1-4-14-11-16(12-15-8-9-18(23)26-19(14)15)21-17(22)7-5-6-10-20-27(24,25)13(2)3;1-12(2)26(23,24)19-11-13(3)4-8-17(21)20-15-6-7-16-14(10-15)5-9-18(22)25-16/h9-12,17-18,21,25H,5-8,13-16H2,1-4H3,(H,26,27);7-12,14-15,24H,4-6,13H2,1-3H3,(H,25,27);3-5,8-9,11-12,14-15,23H,6-7,10,13H2,1-2H3,(H,24,26);9-11,14,16-17H,6-8,12-13H2,1-5H3,(H,22,25)(H,23,26);6-9,14-17,22H,10-13H2,1-5H3,(H2,21,23,25);8-9,11-14,21H,5-7,10H2,1-4H3,(H,22,23);8-9,11-13,20H,4-7,10H2,1-3H3,(H,21,22);5-7,9-10,12-13,19H,4,8,11H2,1-3H3,(H,20,21)/t;;;16-,17+;15?,16-,17+;;;.
What are the key properties of N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-N'-propan-2-ylsulfonylpentanediamide;1-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-3-[2-methyl-3-(propan-2-ylsulfonylamino)propyl]urea;N-(1,3-dioxo-2-phenylisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-ethyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;4-methyl-N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide?
N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-N'-propan-2-ylsulfonylpentanediamide;1-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-3-[2-methyl-3-(propan-2-ylsulfonylamino)propyl]urea;N-(1,3-dioxo-2-phenylisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-ethyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;4-methyl-N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide has a molecular weight of 3407.80 g/mol, XLogP of 24.52, 72 rotatable bonds, 17 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-methylphenyl]-N'-propan-2-ylsulfonylpentanediamide;1-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-3-[2-methyl-3-(propan-2-ylsulfonylamino)propyl]urea;N-(1,3-dioxo-2-phenylisoindol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(8-ethyl-2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;4-methyl-N-(2-oxochromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-(4-methylphenyl)-1,3-dioxoisoindol-5-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(2-oxo-8-propan-2-ylchromen-6-yl)-5-(propan-2-ylsulfonylamino)pentanamide is sourced from PubChem (CID 161290109), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).